Ischemia as a common trigger for Alzheimer's disease
- PMID: 36225888
- PMCID: PMC9549288
- DOI: 10.3389/fnagi.2022.1012779
Ischemia as a common trigger for Alzheimer's disease
Abstract
Alzheimer's disease has various potential etiologies, all culminating in the accumulation of beta -amyloid derivatives and significant cognitive decline. Vascular-related pathology is one of the more frequent etiologies, especially in persons older than 65 years, as vascular risk factors are linked to both cerebrovascular disease and the development of AD. The vascular patho-mechanism includes atherosclerosis, large and small vessel arteriosclerosis, cortical and subcortical infarcts, white matter lesions, and microbleeds. These insults cause hypoperfusion, tissue ischemia, chronic inflammation, neuronal death, gliosis, cerebral atrophy, and accumulation of beta-amyloid and phosphorylated tau proteins. In preclinical studies, hyperbaric oxygen therapy has been shown to reverse brain ischemia, and thus alleviate inflammation, reverse the accumulation of beta-amyloid, induce regeneration of axonal white matter, stimulate axonal growth, promote blood-brain barrier integrity, reduce inflammatory reactions, and improve brain performance. In this perspective article we will summarize the patho-mechanisms induced by brain ischemia and their contribution to the development of AD. We will also review the potential role of interventions that aim to reverse brain ischemia, and discuss their relevance for clinical practice.
Keywords: Alzheimer’s disease; brain oxygenation; cerebral ischemia; cognitive improvement; hyperbaric oxygen (HBO) therapy; neuroinflammation.
Copyright © 2022 Elman-Shina and Efrati.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.J Neurosci Res. 2017 Apr;95(4):943-972. doi: 10.1002/jnr.23777. Epub 2016 Jun 27. J Neurosci Res. 2017. PMID: 27350397 Review.
-
Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.Brain. 2017 Jul 1;140(7):1987-2001. doi: 10.1093/brain/awx112. Brain. 2017. PMID: 28575149 Free PMC article.
-
Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.Ageing Res Rev. 2018 Nov;47:41-48. doi: 10.1016/j.arr.2018.06.002. Epub 2018 Jun 26. Ageing Res Rev. 2018. PMID: 29898422
-
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018. Neuroimage Clin. 2018. PMID: 30023169 Free PMC article.
-
Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.J Alzheimers Dis. 2020;73(1):39-58. doi: 10.3233/JAD-190764. J Alzheimers Dis. 2020. PMID: 31815697 Review.
Cited by
-
A Look at the Etiology of Alzheimer's Disease based on the Brain Ischemia Model.Curr Alzheimer Res. 2024;21(3):166-182. doi: 10.2174/0115672050320921240627050736. Curr Alzheimer Res. 2024. PMID: 38963100 Review.
-
Contribution of Extracellular Vesicles and Molecular Chaperones in Age-Related Neurodegenerative Disorders of the CNS.Int J Mol Sci. 2023 Jan 4;24(2):927. doi: 10.3390/ijms24020927. Int J Mol Sci. 2023. PMID: 36674442 Free PMC article. Review.
-
Post-Ischemic Permeability of the Blood-Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer's Disease-Type Brain Neurodegeneration.Int J Mol Sci. 2023 Jun 27;24(13):10739. doi: 10.3390/ijms241310739. Int J Mol Sci. 2023. PMID: 37445917 Free PMC article. Review.
-
Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids.Molecules. 2023 Jul 25;28(15):5624. doi: 10.3390/molecules28155624. Molecules. 2023. PMID: 37570596 Free PMC article. Review.
-
Are Ischemic Stroke and Alzheimer's Disease Genetically Consecutive Pathologies?Biomedicines. 2023 Oct 8;11(10):2727. doi: 10.3390/biomedicines11102727. Biomedicines. 2023. PMID: 37893101 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources